Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

268
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
268
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

587
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
587
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

262
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
262
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

588
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
588
Seizures: Classification01:13

Seizures: Classification

570
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
570
Notch Signaling Pathway03:14

Notch Signaling Pathway

4.4K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhalation of Environmental Polystyrene Micro/Nanoplastics Induces Pulmonary Toxicity and Synergistically Exacerbates Acute Lung Injury in Male Mice.

Journal of applied toxicology : JAT·2026
Same author

Corrigendum to "Activation of autophagy-lysosome function by MiT/TFE transcription factors ameliorates pulmonary endothelial injury" [Life Sci. 400 (2026) 124469].

Life sciences·2026
Same author

Restoring BECN1-mediated autophagy mitigates acute lung injury caused by zinc oxide nanoparticles.

Free radical biology & medicine·2026
Same author

Myeloid-specific Becn1 deficiency elicits spontaneous pulmonary injury and exacerbates acute lung injury.

Respiratory research·2026
Same author

Bimodal Thermoelectric/AIE E-Skin Decouples Contact-Area Ambiguity for Concurrent Pain Perception and Injury Mapping.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Single-nucleus analysis reveals human-specific oligodendrocyte polarization and conserved neuronal responses after severe traumatic brain injury.

Nature communications·2026

Related Experiment Video

Updated: Sep 2, 2025

Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy
08:26

Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy

Published on: October 19, 2021

5.8K

Beclin1 Deficiency Suppresses Epileptic Seizures.

Min Yang1, Peijia Lin1, Wei Jing1

  • 1Chongqing Key Laboratory of Neurology, Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Frontiers in Molecular Neuroscience
|August 8, 2022
PubMed
Summary

Beclin1, a key protein in cell degradation, is linked to epilepsy. Reducing Beclin1 levels may offer a new strategy for treating epilepsy by suppressing seizure activity and excitatory transmission.

Keywords:
Beclin1dendritic spinesepilepsyexcitatory synaptic transmissiontransgenic mice

More Related Videos

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.1K
Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy
09:29

Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy

Published on: August 17, 2021

2.5K

Related Experiment Videos

Last Updated: Sep 2, 2025

Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy
08:26

Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy

Published on: October 19, 2021

5.8K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.1K
Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy
09:29

Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy

Published on: August 17, 2021

2.5K

Area of Science:

  • Neuroscience
  • Cell Biology
  • Molecular Biology

Background:

  • Epilepsy is a common neurological disorder characterized by recurrent seizures.
  • Autophagy, a cellular degradation process, is implicated in epilepsy, with seizures activating this pathway.
  • Beclin1 is a critical protein in autophagy, involved in various physiological and pathological processes, but its specific role in epilepsy is not fully understood.

Purpose of the Study:

  • To investigate the role of Beclin1 in temporal lobe epilepsy (TLE).
  • To explore the potential of Beclin1 as a therapeutic target for epilepsy.

Main Methods:

  • Examined Beclin1 expression in brain tissues from TLE patients.
  • Utilized two mouse epilepsy models with heterozygous disruption of the beclin1 gene.
  • Assessed seizure susceptibility and activity.
  • Investigated the impact on excitatory synaptic transmission and dendritic spine density.

Main Results:

  • Beclin1 expression was elevated in brain tissues of TLE patients.
  • Heterozygous disruption of beclin1 reduced epilepsy susceptibility and suppressed seizure activity in mouse models.
  • Heterozygous beclin1 disruption was found to suppress excitatory synaptic transmission, potentially due to decreased dendritic spine density.
  • Beclin1's role in synaptic transmission and dendritic spine development may be independent of its function in autophagy.

Conclusions:

  • Beclin1 plays a significant role in epilepsy.
  • Targeting Beclin1 presents a potential novel therapeutic strategy for epilepsy.
  • Beclin1 is involved in synaptic transmission and dendritic spine development, suggesting functions beyond its established role in autophagy.